Accuray Incorporated (ARAY)
Healthcare
Medical Devices
0.27 $
-5.9%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Accuray Incorporated (ARAY)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 95.0% of the shares are freely tradable; institutional investors hold 69.1%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
69.1%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
4.4%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
95.0%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
6.7%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
119Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| TCW Group Inc | 13.00 | 15,467,952 | +0.0 | 03/31/2026 |
| BlackRock Inc | 7.11 | 8,458,409 | -1.0 | 03/31/2026 |
| Neuberger Berman Group LLC | 4.92 | 5,855,064 | +17.9 | 03/31/2026 |
| Vanguard Group Inc | 4.89 | 5,818,576 | +6.2 | 12/31/2025 |
| Armistice Capital, LLC | 4.74 | 5,636,000 | +25.2 | 03/31/2026 |
| Weber Capital Management LLC | 4.25 | 5,055,294 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.72 | 4,430,392 | +0.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.62 | 3,122,473 | +0.0 | 04/30/2026 |
| iShares Russell 2000 ETF | 2.04 | 2,422,602 | +0.9 | 05/29/2026 |
| Acuitas US Microcap Strategy | 2.01 | 2,392,126 | +0.0 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.